|
Acupuncture to Improve Quality of Life in Patients With Advanced Cancer Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Acupuncture to Improve Quality of Life in Patients With Advanced Cancer conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Acupuncture to Improve Quality of Life in Patients With Advanced Cancer Clinical research trials and Acupuncture to Improve Quality of Life in Patients With Advanced Cancer healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Acupuncture to Improve Quality of Life in Patients With Advanced Cancer. Acupuncture to Improve Quality of Life in Patients With Advanced Cancer Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Acupuncture to Improve Quality of Life in Patients With Advanced Cancer clinical trial. Participants typically obtain the most effective healthcare available for their Acupuncture to Improve Quality of Life in Patients With Advanced Cancer condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > Acupuncture to Improve Quality of Life in Patients With Advanced Cancer  Acupuncture to Improve Quality of Life in Patients With Advanced Cancer
Acupuncture to Improve Quality of Life in Patients With Advanced Cancer
For Condition: Ovarian Cancer
Status: Recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) , National Cancer Institute (NCI)
Synopsis: This study will test the effectiveness of acupuncture as a complementary therapy for advanced cancer by comparing symptoms and quality of life before and after 8 weeks of acupuncture treatments.
Details: A large percentage of the practice and use of complementary and alternative medicine (CAM) in the United States is focused on cancer. Whether the CAM use is aimed at reducing one's risk of developing cancer or improving the quality of life of a cancer patient during treatment or at the end of life, the public focus on CAM and cancer has created a driving force for cancer centers to address the efficacy and science of these methods. Currently, the majority of cancer patients do not receive adequate palliative care. Acupuncture has been shown to be effective in the treatment of pain and nausea and has also been shown to improve one's general well-being. Acupuncture also has some effectiveness in relieving symptoms of anxiety and depression. This study will evaluate the efficacy of acupuncture by Traditional Chinese Medicine clinicians to address the quality of life and symptoms of patients with incurable cancer. Women with recurrent metastatic ovarian cancer and similar patients with advanced cancer who are ambulatory and receiving conventional palliative care will be enrolled in this study. Patients will continue to receive high-quality, conventional clinical interventions, including chemotherapy and pain and symptom reduction programs. Patients will also receive 8 weeks of acupuncture. Evaluation tools such as Satisfaction with Life Domains Scale for Cancer (SLDS-C), Brief Pain Inventory, and Rotterdam Symptom Check List will be used to assess the acupuncture intervention.
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Single Group Assignment, Efficacy Study
Minimum Age/Maximum Age: 21 Years/
Genders: Female
Protocol Entry Criteria: Inclusion Criteria - Advanced cancer patients, primarily ovarian cancer patients - Undergoing palliative care treatment - Ambulatory - Symptomatic with pain, nausea, and/or an inadequate quality of life - Platelets > 25,000/mm3 - ANC > 500 cells/mm3 Exclusion Criteria - Acupuncture treatment during the 6 months prior to study entry - History of bleeding disorder, such as hemophilia or von Willebrand disease - Acute psychosis
Total Enrollment: 40
Location and Contact Information:
Overall Study Official:
DavidRosenthal, Principal Investigator, Dana-Farber/Harvard Cancer Center
Dana-Farber Cancer Institute *Recruiting*
Boston, Massachusetts, 02115
United States
Recruiting David Rosenthal 617-495-2010
Additional Information:
Study ID Numbers: 1 R21 AT01010-01;
Study Start Date: September 2001
Record last reviewed: October 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00070967
Other Ovarian Cancer Studies:
1. A Study to Evaluate the Safety and Effect of Pertuzumab on Cancerous Lesions in Women with Advanced, Refractory or Recurrent Ovarian Cancer
2. Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
3. A clinical efficacy study of an oral tyrosine kinase inhibitor of VEGFR-2 to treat recurrent or persistent small-volume epithelial ovarian cancer, primary peritoneal serous cancer, or fallopian tube cancer
4. SU5416 and Carboplatin to Treat Ovarian Cancer
5. Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Related Studies:
Other Ovarian Cancer Clinical Trials
Other Massachusetts Clinical Trials
Other Boston Clinical Trials
Acupuncture to Improve Quality of Life in Patients With Advanced Cancer
|
|
|
|
|
|
|
|
